Sage Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	38,592	42,883	50,417	49,306	77,222	77,039	Upgrade
Market Cap Growth	-35.87%	-14.94%	2.25%	-36.15%	0.24%	-3.55%	Upgrade
Enterprise Value	39,525	38,653	46,918	46,712	82,326	78,452	Upgrade
Last Close Price	332.00	273.00	359.00	348.25	560.00	505.00	Upgrade
PE Ratio	31.48	411.60	298.22	126.39	-	-	Upgrade
PS Ratio	1.09	1.12	1.67	1.69	4.18	6.41	Upgrade
PB Ratio	3.26	2.18	3.42	2.94	4.77	4.37	Upgrade
P/FCF Ratio	-	29.40	17.34	7.35	69.76	-	Upgrade
P/OCF Ratio	-	14.29	12.69	6.32	34.88	-	Upgrade
EV/Sales Ratio	1.13	1.01	1.55	1.61	4.45	6.53	Upgrade
EV/EBITDA Ratio	11.73	12.45	15.42	16.52	-	-	Upgrade
EV/EBIT Ratio	14.91	15.08	18.75	21.97	-	-	Upgrade
EV/FCF Ratio	12.26	26.50	16.14	6.96	74.37	-	Upgrade
Debt / Equity Ratio	2.01	0.96	1.05	1.08	1.21	0.72	Upgrade
Debt / EBITDA Ratio	6.92	5.64	4.75	5.99	-	-	Upgrade
Debt / FCF Ratio	7.38	12.90	5.30	2.70	17.65	-	Upgrade
Asset Turnover	0.66	0.72	0.70	0.61	0.42	0.31	Upgrade
Quick Ratio	1.20	2.02	2.20	2.30	2.56	2.28	Upgrade
Current Ratio	1.24	2.10	2.27	2.38	2.63	2.37	Upgrade
Return on Equity (ROE)	8.76%	0.55%	1.16%	2.42%	-17.67%	-28.24%	Upgrade
Return on Assets (ROA)	3.19%	3.02%	3.62%	2.80%	-3.85%	-9.01%	Upgrade
Return on Capital (ROIC)	4.92%	4.24%	5.18%	3.86%	-5.02%	-12.51%	Upgrade
Return on Capital Employed (ROCE)	8.90%	6.40%	7.50%	5.40%	-	-	Upgrade
Earnings Yield	3.18%	0.24%	0.34%	0.79%	-3.93%	-7.46%	Upgrade
FCF Yield	8.36%	3.40%	5.77%	13.61%	1.43%	-6.43%	Upgrade
Buyback Yield / Dilution	-4.66%	-4.04%	4.30%	-6.15%	-1.76%	4.12%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.